Standard Recommendations For The Application Of Chinese Clinical Cell Therapy For Neurorestoration (2012)

Xijing He,Huancong Zuo,Lin Chen,Tiansheng Sun,Gengsheng Mao,Guoming Luan,Shiqing Feng,Nanbert Zhong,Qiang Ao,Qin Huang,Zonghui Liu,Zuo Luan,Yong Man,Zuncheng Zheng,Yaojian Rao,Zhihai Fan,Guanghong Xiang,Yunliang Wang,Huailin Wang,Yingjie Lu,Xuefeng Lv,Tongchao Geng,Hongyan Xing,Tong Li,Hongyun Huang

DOI: https://doi.org/10.3727/096368913X672082

2013-01-01

Cell Transplantation

Abstract:Cell therapy has been shown to be a promising alternative therapy for neurorestoration, and more than 30 different types of cells have been shown to possess some capability to restore lost or damaged neurological functions. Chinese physicians have successfully applied cell therapy to many neurological diseases and damages in the clinic and contributed to establish a discipline of neurorestoratology. To standardize the clinical procedures of cell therapy as one of the strategies for treating neurological disorders, the Chinese Branch of the International Association of Neurorestoratology (IANR) and the Preparatory Committee of Chinese Association of Neurorestoratology recently completed the Standard Recommendations (2012) for the Application of Chinese Clinical Cell Therapy for Neurorestoration. We hope these recommendations will guide clinical practice in applying cell therapy for neurorestoration, which will therein offer a reference for both Chinese and other countries' governments to make relevant official regulations. This manuscript is published as part of the International Association of Neurorestoratology (IANR) supplement issue of Cell Transplantation.